Ingevity Corp Files 8-K on Director Changes and Compensation

Ticker: NGVT · Form: 8-K · Filed: 2025-05-01T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, executive-compensation, board-of-directors

Related Tickers: NGVT

TL;DR

NGVT 8-K: Board changes & exec comp updates filed April 30.

AI Summary

On April 30, 2025, Ingevity Corporation filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing also includes information on matters submitted to a vote of security holders and financial statements. Specific details regarding the nature of the director changes or compensation adjustments were not elaborated upon in the provided text.

Why It Matters

This filing signals potential shifts in corporate governance and executive remuneration, which can impact investor confidence and the company's strategic direction.

Risk Assessment

Risk Level: low — The filing is routine and reports on standard corporate governance matters without indicating any immediate financial distress or significant operational changes.

Key Players & Entities

FAQ

What specific changes were made to Ingevity Corporation's board of directors?

The filing indicates changes in directors but does not specify the nature of these changes, such as new appointments or departures, in the provided text.

What are the details of the compensatory arrangements for Ingevity's officers?

The filing mentions compensatory arrangements of certain officers as an item of disclosure, but the specific details of these arrangements are not provided in the excerpt.

Were any matters submitted to a vote of Ingevity's security holders?

Yes, the filing indicates that matters were submitted to a vote of security holders, as listed under 'ITEM INFORMATION'.

What is the SIC code for Ingevity Corporation?

The Standard Industrial Classification (SIC) code for Ingevity Corporation is 2800, which falls under 'CHEMICALS & ALLIED PRODUCTS'.

When was Ingevity Corporation incorporated?

Ingevity Corporation was incorporated in Delaware.

From the Filing

0001653477-25-000058.txt : 20250501 0001653477-25-000058.hdr.sgml : 20250501 20250501165531 ACCESSION NUMBER: 0001653477-25-000058 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250430 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250501 DATE AS OF CHANGE: 20250501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ingevity Corp CENTRAL INDEX KEY: 0001653477 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 474027764 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37586 FILM NUMBER: 25904091 BUSINESS ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 BUSINESS PHONE: 8437402300 MAIL ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 8-K 1 ngvt-20250430.htm 8-K ngvt-20250430 false Ingevity Corp 0001653477 0001653477 2025-04-30 2025-04-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________  FORM 8-K _______________________________________________________________________ CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 April 30, 2025 Date of Report (date of earliest event reported) __________________________________________________________________________ INGEVITY CORPORATION (Exact name of registrant as specified in its charter) __________________________________________________________________________  Delaware 001-37586 47-4027764 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 4920 O'Hear Avenue Suite 400 North Charleston South Carolina 29405 (Address of principal executive offices) (Zip code) Registrant’s telephone number, including area code: 843 - 740-2300 Not Applicable (Former name or former address, if changed since last report) _____________________________________________________________________________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock ($0.01 par value) NGVT New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☐ Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act o _____________________________________________________________________________________________________ ITEM 5.02. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSA

View on Read The Filing